- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04779827
Improving Health Equity for COVID-19 Vaccination for At-risk Populations Using Online Social Networks
Improving Health Equity for COVID-19 Vaccination and Related Health Behaviors for At-risk Populations Using Online Social Networks
Social technologies for health have already become essential means for providing underserved populations greater social connectedness and increased access to novel health information. However, these technologies have also had negative unintended consequences. The resulting digital divide in social technology takes many forms - from explicit racism that excludes African American and Latinx populations from the resources enjoyed by White and Asian members of online communities, to self-segregation for the purposes of identity preservation and community-building that unintentionally results in limited informational diversity in underserved communities. The result is an often unnoticed, but highly consequential compounding of inequities.
This research seeks to use an online social network approach to address these challenges, in which the investigators demonstrate how reducing the online levels of network centralization and network homophily among African American community members directly increases their productive engagement with health-promoting information.
Study Overview
Status
Conditions
Detailed Description
To investigate the causal effects of network structure and composition on the acceptance of new or unfamiliar behavior-relevant health information, the investigators propose a randomized controlled experiment that compares several independent populations to identify and address participants' endorsement of biased information, and engagement with novel behavior relevant information (e.g., regarding COVID-19 vaccination). Each population will have its own network structure (i.e., level of centralization) and composition (i.e., level of homophily).
To run each experimental trial, the investigators will recruit 240 African American participants, aged 18 to 40, collectively to answer behavior-relevant questions over a period of no greater than 8 minutes. Participants can respond asynchronously - i.e., when the participants' time permits. As with previous studies, the technical infrastructure will manage participants' progress through the study to ensure that all participants have the relevant information about each other's responses.
To ensure causal identification, each network graph will constitute a single observation of how individual decisions change under conditions of interdependent social information. Thus, each trial of 240 people (6 networks x 40 participants per network) produces 6 observations of a community-level social learning process. Power calculations indicate that 8 independent trials are sufficient to produce results of p<0.05 with 85% power, resulting in a desired population of 1920 participants for each health topic (e.g., COVID-19 vaccination is a single "health topic"), producing 48 independent observations of collective decision making per health topic.
The studies will target health topics for which there is substantial racial disparity in outcomes and behavior, such as acceptance of COVID-19 vaccination, and spreading of various categories of COVID-19 misinformation (e.g. beliefs related to assessment of personal risk, effectiveness of protective behaviors, methods of transmission, disease prevention, treatment, origins of the virus) and related health practices (e.g. choice of appropriate contraceptive methods, value of heart disease screenings, etc.).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Damon Centola
- Phone Number: 215-898-7954
- Email: dcentola@asc.upenn.edu
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Annenberg School for Communication
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Having internet access
- Aged 18 and above
- Living in the United States
Exclusion Criteria:
- Having no internet access
- Aged below 18
- Living outside of the United States
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Egalitarian Networks of Homogeneous Populations
Egalitarian networks are characterized by equal connectivity for all participants in an online network for information exchange.
Each network is consisted of 40 individual participants.
All network participants in this condition share similar baseline demographic characteristics, attitudes, or behavioral choices.
|
The online network intervention aims to use different configurations of online social networks to optimize the impacts of collective intelligence process to improve individuals' understanding, beliefs, and behavioral choices regarding a variety of health behaviors.
Participants will be put into different online networks and respond to health questions while receiving feedback from their network members.
|
Experimental: Egalitarian Networks of Diverse Populations
Egalitarian networks are characterized by equal connectivity for all participants in an online network for information exchange.
Each network is consisted of 40 individual participants.
All network participants in this condition have very different baseline demographic characteristics, attitudes, or behavioral choices.
|
The online network intervention aims to use different configurations of online social networks to optimize the impacts of collective intelligence process to improve individuals' understanding, beliefs, and behavioral choices regarding a variety of health behaviors.
Participants will be put into different online networks and respond to health questions while receiving feedback from their network members.
|
Experimental: Centralized Networks of Homogeneous Populations
Centralized networks have a small number of influential individuals, called "hubs," with connections to most other people.
Centralized networks characterize situations in which most or all individuals are connected to, and seek advice from, a few well-connected "influencers."
Each network is consisted of 40 individual participants.
All network participants in this condition share similar baseline demographic characteristics, attitudes, or behavioral choices.
|
The online network intervention aims to use different configurations of online social networks to optimize the impacts of collective intelligence process to improve individuals' understanding, beliefs, and behavioral choices regarding a variety of health behaviors.
Participants will be put into different online networks and respond to health questions while receiving feedback from their network members.
|
Experimental: Centralized Networks of Diverse Populations
Centralized networks have a small number of influential individuals, called "hubs," with connections to most other people.
Centralized networks characterize situations in which most or all individuals are connected to, and seek advice from, a few well-connected "influencers."
Each network is consisted of 40 individual participants.
All network participants in this condition have very different baseline demographic characteristics, attitudes, or behavioral choices.
|
The online network intervention aims to use different configurations of online social networks to optimize the impacts of collective intelligence process to improve individuals' understanding, beliefs, and behavioral choices regarding a variety of health behaviors.
Participants will be put into different online networks and respond to health questions while receiving feedback from their network members.
|
Experimental: Independent Control of Homogeneous Populations
Independent control condition does not have online networks.
Participants in this condition are not put into online networks.
Participants only respond to questions by themselves.
All participants in this condition share similar baseline demographic characteristics, attitudes, or behavioral choices.
|
Independent control aims to test the baseline of population understanding of health behaviors and choices.
Participants will respond to health questions independently without getting any feedback from others.
|
Experimental: Independent Control of Diverse Populations
Independent control condition does not have online networks.
Participants in this condition are not put into online networks.
Participants only respond to questions by themselves.
All participants in this condition have very different baseline demographic characteristics, attitudes, or behavioral choices.
|
Independent control aims to test the baseline of population understanding of health behaviors and choices.
Participants will respond to health questions independently without getting any feedback from others.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
COVID-19 vaccination attitude
Time Frame: Immediate after intervention
|
COVID-19 vaccination attitude scale, which is a self-reported scale measuring participants' attitudes toward COVID-19 vaccination.
The scale is consisted of 5 questions (e.g., "How much confidence do you have that the COVID-19 vaccine in the U.S. is safe and effective?")
with responses ranging from 1 (No confidence at all) to 5 (A great deal of confidence); a higher average score means a more positive attitude in favor of COVID-19 vaccination.
|
Immediate after intervention
|
COVID-19 vaccination intention
Time Frame: Immediate after intervention
|
COVID-19 vaccination intention scale, which is a self-reported scale measuring participants' intention toward COVID-19 vaccination.
The scale is consisted of 5 questions (e.g., "Would you get a COVID-19 vaccine when it is available to you?") with responses ranging from 1 (Definitely Not) to 5 (Definitely); a higher average score means a stronger intention to receive the COVID-19 vaccine.
|
Immediate after intervention
|
COVID-19 vaccine safety perception
Time Frame: Immediate after intervention
|
One question asks participant's estimation of one potential side effect from the COVID-19 vaccine.
The question asks "According to the most recent data, for every 10 million people in the US vaccinated for COVID-19, how many experienced a severe allergic reaction (anaphylaxis)?
Answer must be between 0 and 10,000."
|
Immediate after intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
COVID-19 vaccine belief
Time Frame: Immediate after intervention
|
COVID-19 vaccine belief scale, which is a self-reported scale measuring participants' knowledge and belief (including misbelief) about the COVID-19 vaccine safety and effectiveness.
The scale is consisted of 12 items (e.g., "A COVID-19 vaccine will not alter my DNA") with responses ranging from 1 (completely disagree) to 5 (completely agree); a higher average score means more accurate knowledge and belief towards the COVID-19 vaccine.
|
Immediate after intervention
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Damon Centola, PhD, University of Pennsylvania
Publications and helpful links
General Publications
- Guilbeault D, Centola D. Networked collective intelligence improves dissemination of scientific information regarding smoking risks. PLoS One. 2020 Feb 6;15(2):e0227813. doi: 10.1371/journal.pone.0227813. eCollection 2020.
- Guilbeault D, Becker J, Centola D. Social learning and partisan bias in the interpretation of climate trends. Proc Natl Acad Sci U S A. 2018 Sep 25;115(39):9714-9719. doi: 10.1073/pnas.1722664115. Epub 2018 Sep 4.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 827141
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Diseases
-
Baker Heart and Diabetes InstitutePrincess Alexandra Hospital, Brisbane, Australia; Royal Perth Hospital; Alice... and other collaboratorsRecruitingHeart Failure | Valve Heart DiseaseAustralia
-
Medical University of ViennaUnknownHeart Diseases | Heart Failure | Valvular Heart DiseaseAustria
-
Centre Chirurgical Marie LannelongueActive, not recruitingValvular Heart Disease | Valve Disease, Heart
-
Kathirvel SubramaniamUniversity of Maryland, Baltimore; CSL BehringRecruitingHeart Failure,Congestive | Heart Disease End StageUnited States
-
University of MichiganTerminatedDiastolic Heart Failure | Hypertensive Heart DiseaseUnited States
-
Abiomed Inc.RecruitingHeart Diseases | Acute Decompensated Heart Failure | Congestive Heart Failure | Acute Heart FailureUnited States
-
Wuerzburg University HospitalRecruitingHeart Failure | Chronic Heart Failure | Chronic Heart DiseaseGermany
-
Yonsei UniversityCompletedMitral Valvular Heart Disease
-
Aristotle University Of ThessalonikiRecruitingCardiovascular Diseases | Heart Failure | Valvular Heart Disease | Biochemical DysfunctionGreece
-
University College, LondonBritish Heart Foundation; Horizon 2020 - European CommissionRecruitingValvular Heart DiseaseUnited Kingdom
Clinical Trials on Online Social Network and Collective Intelligence Intervention
-
University of the PhilippinesPhilippine Dermatological SocietyCompleted
-
Nantes University HospitalCompleted
-
Kent State UniversityUnknownQuality of Life | Emotional Intelligence | Social CompetenceUnited States
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedOverweight and ObesityUnited States
-
Medical College of WisconsinNational Institute of Mental Health (NIMH)CompletedHIV InfectionsBulgaria, Hungary, Russian Federation
-
Medical College of WisconsinNational Institute on Drug Abuse (NIDA)CompletedSexually Transmitted Diseases | HIVEl Salvador
-
Medical College of WisconsinNational Institute of Mental Health (NIMH)Completed
-
Hennepin Healthcare Research InstituteUniversity of MinnesotaUnknownKidney TransplantUnited States
-
Wake Forest University Health SciencesAmerican Heart AssociationCompleted
-
Medical College of WisconsinMississippi State University; AIDS Task Force of Greater ClevelandCompleted